H. P. Yu

In-vitro inhibitory activities of 2 new orally absorbable imidazole derivatives: BAY n 7133 and BAY 1 9139.

R. Fromtling, S. Shadomy, H. P. Yu, 1983, Sabouraudia.

Treatment of systemic mycoses with ketoconazole: in vitro susceptibilities of clinical isolates of systemic and pathogenic fungi to ketoconazole.

W. Dismukes, S. Shadomy, W E Dismukes, 1985, The Journal of infectious diseases.

In Vitro Studies with Ambruticin, a New Antifungal Antibiotic

A. Espinel-Ingroff, S. Shadomy, H. J. Shadomy, 1978, Antimicrobial Agents and Chemotherapy.

In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts

R. Fromtling, S. Shadomy, H. P. Yu, 1984, Mycopathologia.

The effect of human bcl-2 and bcl-X genes on dengue virus-induced apoptosis in cultured cells.

Y. L. Lin, C. Liao, H. Su, 2001, Virology.